Insurance

AIA makes major play in health insurance market

Thursday 1st of October 2015

The new Real Health product introduces new $500,000 limits on surgical and non-surgical treatments, including new generation, non-Pharmac treatments for cancer, such as the innovative immunotherapy treatments, that are otherwise unaffordable for the average New Zealander.

AIA chief executive Natalie Cameron says: “Our new Real Health policy directly addresses the affordability issues for...

Want to read the full article?
Click the button below to subscribe and will have unlimited access to full article and all other articles on the site.